Searched for
PFIZER CLARIS
Cadila Healthcare to acquire Claris Lifesciences for Rs 3,400 croreBoth sides are currently engaged in last-minute due diligence negotiations involving tax and other financial matters, said at least five so...- Claris surges 18% as pharma cos in race to buy injectible bizLupin, Cipla Zydus Cadilla and US-based Amneal are competing with other global peers signaling the continuing appeal of quality Indian phar...
- Big pharma eyes takeover of Claris’ injectables business for Rs 2500-Rs 3000 croreCarlyle private equity backed CLL has transferred its speciality injectables business into a wholly owned subsidiary called CIL.
- Claris Lifesciences gets USFDA drug approvalClaris Lifesciences Ltd, a parenteral drug company has received drug approval from US drug authorities for hypertension and angina treatmen...
- Claris Lifesciences in talks with Otsuka Pharma to sell injectables business: SourcesShares of Claris have rallied 165 per cent from the start of the year and are currently trading at their lifetime high.
- Claris Lifesciences Net Profit dips 27%, revenue down by 5%Claris Lifesciences Ltd, net profit dips successive for second time in a year. The net profit for the third quarter dropped by 27.34% and r...
- Mitsui in talks to invest Rs 250 crore in ClarisSources said the Japanese group's healthcare company might pick up stake from private equity players invested in Claris or invest in a join...
- Adani group, Claris Lifesciences stock prices fall sharplyStock prices of Adani group companies and Claris Lifesciences fell sharply on Monday when the benchmark BSE Sensex closed 104 points lower.
- Pfizer ends supply deal with Claris LifesciencesMultinational drug-maker Pfizer Inc has terminated its three-year old supply deal with Claris Lifesciences, immediately after a ban on the ...
- Morgan Stanley, Barclays buy Claris bulk shares in open market on USFDA clearanceClaris said it has formally received the letter from USFDA stating that it has completed its evaluation of the firm's corrective actions.
- Claris Lifesciences net profit falls 14%, USFDA clearance awaitingThe consolidated net profit stood at Rs 32.32 crore for second quarter ended on 30 June 2012 compared to Rs 37.72 crore for the same period...
- Claris Lifesciences yet to get USFDA clearanceClaris Lifesciences said its consolidated net profit rose 9% for the first quarter of calendar year 2012 to Rs 21.7 crore.
- USFDA to inspect facilities of Zydus, Claris Lifesciences for violating American drug manufacturing normsFDA had issued warning letter for Cadila's injectable unit at its plant in July for not meeting US drug manufacturing norms .
- Claris gets Russian nod for anti-infective drugsClaris raised Rs 300 crore in December through its maiden IPO. On Thursday, its stock dipped 2.48% to close at Rs 161.40.
- Subscribe to Claris Lifesciences IPO: Nirmal BangThe company has entered primary markets by offering shares in price band of Rs 278-293.
- Claris gets nod for Rs 300-crore IPOClaris Lifesciences Ltd, has finally received approval from SEBI for its maiden public issue to raise Rs 300 crore.
- Pfizer recalls drug from USPFIZER has recalled a drug made by an Indian partner from the US market while another local partner of the world’s largest drugmaker receiv...
- Claris recalls three anti-biotic drugs from USAhmedabad-based drug-maker Claris Lifesciences on Monday recalled three antibiotic drugs from the US market following an alert issued by th...
- Cipla in talks with global cos for research agreementMumbai-based drugmaker Cipla is in talks with global pharma majors for a drug research and supply agreement, said a top company executive o...
- Pfizer ties up with Claris for injectablesWorld No 1 pharma company Pfizer on Wednesday announced a marketing tie-up with Rs 800-crore Ahmedabad-based Claris Lifesciences, that spec...
Load More
